FDA Ad Enforcement Steams On; Are “Days Of Pushing The Envelope” Over?
Executive Summary
FDA's aggressive enforcement of its advertising standards, and the agency's new enforcement allies, mean that industry may now have more to fear from a citation letter
You may also be interested in...
FDA's Executive Responsibility Policy Could Sweep In Board Members
Add board members to the list of company executives who could be personally affected by FDA's plans to focus on responsible individuals in the corporations it takes to task as part of its enforcement mission.
FDA's Executive Responsibility Policy Could Sweep In Board Members
Add board members to the list of company executives who could be personally affected by FDA's plans to focus on responsible individuals in the corporations it takes to task as part of its enforcement mission.
FDA's Drug Advertising Oversight Gets A Promotion From A Division To An Office
The Division of Drug, Advertising, Marketing and Communications will consist of an office with two divisions, one to review materials for healthcare professionals and other to review direct-to-consumer promotions.